EVMN

NYSE Evommune, Inc.

Oct 23, 2026 · 7:53 PM ET LAST TRADE Market Closed

$5.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $5.10, $0.08 below the day’s high of $5.18

YTD change: -70.21%
vs 20-day SMA: -21.29%
vs 200-day SMA: -71.93%

Price ranges

Previous day

$5.10 $5.37

open $5.13 close $5.21

+$0.08 (+1.56%)

Today

$4.94 $5.18

open $5.18 now $5.10

-$0.08 (-1.54%)

Past week

$5.09 $6.00

from $5.93 now $5.10

-$0.83 (-14.00%)

Past month

$5.09 $8.80

from $8.80 now $5.10

-$3.70 (-42.05%)

This year

$4.94 $33.20

from $17.12 now $5.10

-$12.02 (-70.21%)

Price & Performance

-20.63 (-79.84%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 84.6% away from all-time highs of $33.20
EVMN is down 70% since the beginning of the year
EVMN is down 75% over the past 12 months
EVMN is down 42% over the past 1 month
13% of all EVMN investors are betting against EVMN
Number of investors short EVMN has gone down 38% versus last month

EVMN reads poor: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -74.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.89

Earnings momentum -6.8% Quarterly EPS growth

Quarterly change -6.8%

Valuation

P/E ratio N/A

Enterprise value $-3897290.0

Beta 1.40

Balance sheet & scale

IncomeN/A

Revenue$10.0M

Cash$200.8M

Debt$8.6K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $185.1M

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,306.69	+2.83%
JNJ	Johnson & Johnson	$267.61	+3.81%
ABBV	AbbVie, Inc.	$285.19	+0.14%
MRK	Merck & Co., Inc.	$147.24	-1.76%
RHHBY	Roche Holding Ltd Sponsored ADR	$59.62	+0.86%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.